Elsevier

Neuroscience

Volume 48, Issue 3, June 1992, Pages 545-559
Neuroscience

Serotonin-, substance P- and glutamate/aspartate-like immunoreactivities in medullo-spinal pathways of rat and primate

https://doi.org/10.1016/0306-4522(92)90401-MGet rights and content

Abstract

Serotonergic neurons of the medulla oblongata have been proposed to play a role in the control of sensory, motor and autonomic cells in the spinal cord. Many of these raphe neurons have been shown to contain the undecapeptide substance P as well as the tripeptide thyrotropin-releasing hormone, but evidence for the presence of an excitatory arnino acid in these pathways has not yet been documented. In colchicine-treated rats, we have used a combination of retrograde tracing and tri-color immunohistofluorescence techniques to study co-localization of serotonin- and substance P- with glutamate- or aspartate-like immunoreactivities in medullary neurons and the possible spinal projections of these cells. In addition, the distributions of serotonin-, substance P- and glutamate-immunoreactive terminal fields in the dorsal, ventral and lateral horns of the spinal cord were examined with tri-color immunofluorescence in the rat and the primate Macaco fasciculata.

In colchicine-treated rats, glutamate- and aspartate-like immunoreactivity was found in practically all serotonin- and substance P-immunoreactive neurons of the B1, B2 and B3 cell groups. Some of these neurons also contained wheat-germ agglutinin conjugated to inactivated horseradish peroxidase and colloidal gold particles retrogradely transported from the spinal cord. In the spinal cords of non-colchicine-treated monkeys and rats, striking co-localization of serotonin, substance P- and glutamate-like immunoreactivities was seen in large boutons, surrounding the dendrites and cell bodies of large alpha motor neurons in the ventral horn.

These observations suggest the existence of spinally projecting serotonin/substance P neurons containing excitatory amino acids such as glutamate or aspartate. Thus, these bulbospinal neurons may utilize three types of messenger molecules, an excitatory amino acid, a biogenic amine and one or more peptides.

References (0)

Cited by (112)

  • What substance P might tell us about the prognosis and mechanism of Parkinson's disease?

    2021, Neuroscience and Biobehavioral Reviews
    Citation Excerpt :

    In the brain, the main sites of SP immunoreactivity are in different areas, often lacking NK1-R: neocortex, limbic areas, habenula, periaqueductal gray matter and midbrain nuclei. High levels of SP/NK1-R immunoreactivity have been identified in hypothalamus, where SP frequently coexists with ‘classical’ neurotransmitters and neuropeptides (Dean et al., 1993; Ebner and Singewald, 2006; Hökfelt et al., 1982; Kachidian et al., 1991; Nicholas et al., 1992; Pickel, 1979). The presence of SP in the hypothalamic nuclei, involving the regulation of stress response and circadian rhythm, such as the paraventricular nucleus of the hypothalamus (PVN) and suprachiasmatic nucleus (SCN) (Ebner and Singewald, 2006), is congruent with neurobehavioral effects of SP, and the link between SP and the psychopathology of mood disorders (Herpfer and Lieb, 2003; Rosenkranz, 2007), and therefore with some non-motor symptoms reported by PD patients, including sleep disturbances, and depression.

  • Serotonin drives striatal synaptic plasticity in a sex-related manner

    2021, Neurobiology of Disease
    Citation Excerpt :

    These findings proved that there is a unique monoaminergic mechanism controlling presynaptic inhibition of corticostriatal glutamate release and, in turn, prompted to investigate how DA and 5-HT systems may interact to influence striatum-dependent processes. This view is supported by the discovery that the raphe neurons, the main source of serotonergic fibers that project to almost all regions of the brain, are immunoreactive for glutamate and vesicular glutamate transporter 3 (VGLUT3) (Gras et al., 2002; Nicholas et al., 1992; Ottersen and Storm-Mathisen, 1984) as well as phosphate-activated glutaminase, an enzyme involved in the glutamate metabolism (Kaneko et al., 1990). Herein, we investigated the involvement of 5-HT in corticostriatal synaptic plasticity of striatal projection neurons (SPNs) recorded from male and female Tph2 knock-in mutant mice (Tph2GFP/GFP), which are depleted of brain 5-HT.

  • Substance P: A neuropeptide involved in the psychopathology of anxiety disorders

    2020, Neuropeptides
    Citation Excerpt :

    It is considered a key player in regulating the psychopathological conditions revealed by various experiments. It also acts as a neuromodulator in brain where it co-exists with various classical neurotransmitters such as glutamate, dopamine, GABA, acetylcholine, serotonin and noradrenaline depending upon the region of brain involved (Nicholas et al., 1992; Dean et al., 1993). SP is designted as the most abundantly found neurokinin peptide that is extensively distributed all over the nervous system (Quartara and Maggi, 1998; Severini, 2002).

  • 5.15 - The Brainstem and Nociceptive Modulation

    2020, The Senses: A Comprehensive Reference: Volume 1-7, Second Edition
  • Preface

    2020, Progress in Brain Research
View all citing articles on Scopus
View full text